PLATO: Difference between revisions
Jump to navigation
Jump to search
(PLATO moved to PLATO bleeding criteria) |
Rim Halaby (talk | contribs) No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{CMG}} | |||
==Overview== | |||
PLATO refers to the PLATelet inhibition and patient Outcomes trial. | |||
[[PLATO bleeding criteria|Click here for PLATO bleeding criteria]] | |||
[[Category:Cardiology]] | |||
[[Category:Clinical research]] | |||
[[Category:Clinical trials]] | |||
Latest revision as of 16:52, 22 April 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
PLATO refers to the PLATelet inhibition and patient Outcomes trial.